Israel Englander Evogene Ltd. Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.47 - $0.88 $16,014 - $29,985	34,074 New	34,074 $28,000
Q1 2023 May 15, 2023	BUY	$0.59 - $0.86 $36,452 - $53,134	61,784 Added 367.22%	78,609 $50,000
Q4 2022 Feb 14, 2023	BUY	$0.61 - $8.13 $1,040 - $13,861	1,705 Added 11.28%	16,825 $12,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $8.65 $2,517 - $29,833	3,449 Added 29.55%	15,120 $13,000

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $69.6M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.